[Sar(1)-Ile(8)]-angiotensin II specifically inhibits aldosterone biosynthesis induced by angiotensin II and its heptapeptide metabolite, indicating the heptapeptide has a higher affinity for the adrenal cortex receptor.
Answers are grounded in this paper and cite their sources.
Selectively blocks angiotensin- but not ACTH-stimulated aldosterone in rabbit cells; leaves open human translation and therapeutic relevance.
The present study determined the effect of [Sar(1)-Ile(8)]-angiotensin II on steroidogenesis and induced aldosterone synthesis by the octapeptide angiotensin II, the heptapeptide des-Asp(1)-angiotensin II, and adrenocorticotropic hormone. Rabbit adrenal cells were suspended by incubation of the capsular cortical tissue with collagenase, and aldosterone levels were determined by immunoassay. Steroidogenic responses to angiotensin II and des-Asp(1)-angiotensin were essentially the same. [Sar(1)-Ile(8)]-angiotensin II (10(-7) to 5 x 10(-7) M) had no significant effect on basal aldosterone biosynthesis. However, when added with steroidogenic peptides, it completely blocked the effect of angiotensin II and des-Asp(1)-angiotensin II but not of adrenocorticotropic hormone. The dose ratio of the antagonist to angiotensin II that gave 100% inhibition was about 2:1 and to des-Asp(1)-angiotensin II, about 50:1. The data suggest that des-Asp(1)-angiotensin II has a much higher affinity for the angiotensin receptor in adrenal cortex than angiotensin II.
No takes yet. Share an insight, caveat, or question.
Chiu et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: